GDTC | CYTOMED THERA | Owners | TradeSmith

S&P 500$7,489.72
+0.70%
2m
DOW 30$52,485.03
+0.53%
2m
NASDAQ 100$28,274.20
+0.60%
2m
Russell 2000$291.20
-0.48%
2m
Russell 1000$408.38
+0.64%
2m
S&P 400$3,758.64
-0.15%
2m
S&P 600$1,768.56
-0.09%
2m

CYTOMED THERA (GDTC)

NASDAQ

$0.93+$0.002 (+0.20%)

Price as of Aug 03, 2026 7:43 AM EDT

$10.2M
Market Cap
-49.17%
1-Year Change
Biotechnology
Industry

Top Holders

Institutional

Mutual Funds

No data found

No data found

Current Ownership Distribution

Other11.2M (95.03%)
Insiders588,355 (4.97%)
Institutions0 (0.00%)
Mutual Funds0 (0.00%)

Insider Transactions

4.97% (588,355)
Current InsiderOwnership (%, shares)
1
Number of InsiderBuying (last 12 months)
$1.4M
Amount of InsiderBuying (last 12 months)
0
Number of InsiderSelling (last 12 months)
$0.00
Amount of InsiderSelling (last 12 months)

Insider Name & Title	Type	Date	Transaction Value	Shares	Share Price	Shares After Transactions
Choo Chee Kong	Buy	Jul 20, 2026	$150,000.00	100,000	$1.50	630,324
Choo Chee Kong	Buy	Jul 14, 2026	$150,000.00	100,000	$1.50	530,324